12-109113703-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001412734.1(ACACB):​c.-10+288G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.537 in 152,140 control chromosomes in the GnomAD database, including 23,633 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.54 ( 23633 hom., cov: 33)

Consequence

ACACB
NM_001412734.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.44

Publications

9 publications found
Variant links:
Genes affected
ACACB (HGNC:85): (acetyl-CoA carboxylase beta) Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis. [provided by RefSeq, Oct 2022]
UNG (HGNC:12572): (uracil DNA glycosylase) This gene encodes one of several uracil-DNA glycosylases. One important function of uracil-DNA glycosylases is to prevent mutagenesis by eliminating uracil from DNA molecules by cleaving the N-glycosylic bond and initiating the base-excision repair (BER) pathway. Uracil bases occur from cytosine deamination or misincorporation of dUMP residues. Alternative promoter usage and splicing of this gene leads to two different isoforms: the mitochondrial UNG1 and the nuclear UNG2. The UNG2 term was used as a previous symbol for the CCNO gene (GeneID 10309), which has been confused with this gene, in the literature and some databases. [provided by RefSeq, Nov 2010]
UNG Gene-Disease associations (from GenCC):
  • hyper-IgM syndrome type 5
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.754 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001412734.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACACB
NM_001412734.1
c.-10+288G>A
intron
N/ANP_001399663.1
ACACB
NM_001412737.1
c.26+288G>A
intron
N/ANP_001399666.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UNG
ENST00000699563.1
c.774+10092G>A
intron
N/AENSP00000514437.1
ENSG00000256139
ENST00000541704.2
TSL:5
n.576+288G>A
intron
N/A
ENSG00000256139
ENST00000755021.1
n.485+288G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.536
AC:
81527
AN:
152022
Hom.:
23588
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.761
Gnomad AMI
AF:
0.326
Gnomad AMR
AF:
0.445
Gnomad ASJ
AF:
0.464
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.501
Gnomad FIN
AF:
0.495
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.424
Gnomad OTH
AF:
0.507
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.537
AC:
81625
AN:
152140
Hom.:
23633
Cov.:
33
AF XY:
0.537
AC XY:
39954
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.761
AC:
31605
AN:
41516
American (AMR)
AF:
0.445
AC:
6798
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.464
AC:
1609
AN:
3470
East Asian (EAS)
AF:
0.707
AC:
3668
AN:
5186
South Asian (SAS)
AF:
0.499
AC:
2407
AN:
4820
European-Finnish (FIN)
AF:
0.495
AC:
5237
AN:
10586
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.424
AC:
28812
AN:
67964
Other (OTH)
AF:
0.509
AC:
1076
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1842
3684
5527
7369
9211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.497
Hom.:
7575
Bravo
AF:
0.539
Asia WGS
AF:
0.609
AC:
2116
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.23
DANN
Benign
0.52
PhyloP100
-3.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34260; hg19: chr12-109551508; API